Exchange: NASDAQ·Updated 07:30 PM EDT

ALGN News

News
all
press releases
Here's How CVS' Improving Balance Sheet Supports Deleveraging
CVS Health's strong cash generation, higher operating cash flow outlook and disciplined capital deployment support continued deleveraging in 2026.
Zacks
More News
Quentin Blackford to Join Align Technology Board of Directors
Align Technology, Inc. (Align) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its...
Business Wire
Why Is Align Technology (ALGN) Down 8.4% Since Last Earnings Report?
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook
Align's $37.5M U.K. VAT liability, new 20% VAT charges and pending appeal add fresh earnings uncertainty amid currency and mix pressures.
Zacks
Should Investors Buy Align as Growth Meets Valuation and Demand Risks?
ALGN's record Clear Aligner growth and global adoption support the bull case, but demand softness and scanner pricing pressure keep investors cautious.
Zacks
Can NVST Sustain Its 2026 Guidance Boost as Margins Keep Expanding?
Envista raises 2026 guidance as stronger sales and expanding margins lift earnings, but China pricing, tariffs and a tougher Q4 loom.
Zacks
Is NVST a Buy as Earnings Rebound but Valuation Remains Above Median?
Envista's earnings rebound and raised 2026 guidance strengthen the case, but above-median valuation leaves less room for execution setbacks.
Zacks
Align Technology Wins China Patent Case Against Angelalign
(RTTNews) - Align Technology, Inc. (ALGN), said the Jinan Intermediate People's Court in China ruled in its favor in a patent infringement case against Angelalign Technology's Chinese operating subsidiaries...
Nasdaq News: Markets
Align Technology Prevails in China Patent Infringement Action Against Angelalign
Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, today announced that the Jinan Intermediate People's Court in China issued a judgment in favor of Align in a patent infringement...
Business Wire
Can Segment Strength Offset Headwinds for BD Stock Before Q3 Earnings?
BDX's Medical Essentials and Interventional strength may drive third-quarter fiscal 2026 results, but China, vaccines and projected declines weigh on expectations.
Zacks

Advertisement|Remove ads.